BOSTON--(BUSINESS WIRE)--The U.S. District Court ruled in favor of Foley Hoag LLP’s client, Dana-Farber Cancer Institute, that Dana-Farber scientist, Gordon Freeman, PhD, and another scientist, Clive Wood, PhD, are co-inventors on a series of cancer immunotherapy patents previously issued to a Japanese researcher and Japanese drug company. The ruling directs that the patents be corrected to name Freeman and Wood as inventors. In her decision, Chief Judge Patti B. Saris wrote that “Dana-Farber h
CRANBURY, N.J.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/Breast?src=hash" target="_blank"gt;#Breastlt;/agt;--Physicians’ Education Resource® to Host ASCO Direct™ Highlights in Kansas City
SAN DIEGO & WALTHAM, Mass.--(BUSINESS WIRE)--Echosens Presents Research Studies at May 2019 Digestive Disease Week: Highlights Value of Non-Invasive Screening for Fatty Liver Disease
REHOVOT, Israel & WILMINGTON, Del.---(BUSINESS WIRE)--Ayala Pharmaceuticals, Inc., a clinical-stage company developing medicines for cancers that are genetically defined, today announced updates on AL101, a pan-Notch inhibitor, that will be presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Il. The details of the poster presentations are as follows: Title: ACCURACY: phase (P) 2 trial of AL101, a pan-Notch inhibitor, in patients (pts) with recurrent/met
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/INDstatus?src=hash" target="_blank"gt;#INDstatuslt;/agt;--PharmaCyte proceeding with GMP production of pancreatic cancer product after successful changes to manufacturing process.
TEL AVIV, Israel & LEHI, Utah--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/dna?src=hash" target="_blank"gt;#dnalt;/agt;--MyHeritage Expands to Health; Launches New DNA Test Offering Powerful and Personalized Health Insights for Consumers.
OLATHE, Kan.--(BUSINESS WIRE)--NIC Inc. has been selected to provide its RxGov prescription drug monitoring platform to the State of Nebraska.
NEWTON, Mass.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/NTI2019?src=hash" target="_blank"gt;#NTI2019lt;/agt;--Cheetah Medical showcases fluid management education with Virtual Trainer app at the 2019 National Teaching Institute & Critical Care Exposition
GERMANTOWN, Md.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/hurricane?src=hash" target="_blank"gt;#hurricanelt;/agt;--Earth Networks released its 2019 Atlantic Hurricane Season Outlook.
MIAMI & JERSEY CITY, N.J.--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Ltd., announced today that secondary endpoint data from the pivotal Phase III study for HP-3070 (asenapine) transdermal drug delivery system (TDDS), an investigational product for the treatment of schizophrenia, will be featured as a poster presentation at the American Psychiatric Association (APA) 172nd Annual Meeting in San Francisco, May 18 – 22, 2019. This post
MENLO PARK, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/RAPIDai?src=hash" target="_blank"gt;#RAPIDailt;/agt;--iSchemaView, the worldwide leader in advanced imaging for stroke, has launched RAPID U, a training certification program for the RAPID platform.
KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind – a leading mental health care company – today announced that its flagship pharmacogenetic product, Genomind Professional PGx™, is now available to patients through their health care providers. Genomind Professional PGx provides personalized analytics on patient-specific genetic markers. This information helps indicate which medications or other treatment options, for more than 11 mental health conditions, are better suited for a patient based on
SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has completed the $1.2 billion acquisition of Paragon Bioservices, Inc., a leading viral vector development and manufacturing partner for gene therapies. With the addition of Paragon’s specialized expertise in adeno-associated virus (AAV) vectors, the most commonly used vect
PARSIPPANY, N.J.--(BUSINESS WIRE)--lt;a href="https://twitter.com/search?q=%24ZTS&src=ctag" target="_blank"gt;$ZTSlt;/agt; lt;a href="https://twitter.com/hashtag/animalhealth?src=hash" target="_blank"gt;#animalhealthlt;/agt;--Zoetis Inc. will present at the Stifel 2019 Dental & Veterinary Conference on May 29 at 10:30 am ET.
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/bioinformatics?src=hash" target="_blank"gt;#bioinformaticslt;/agt;--DNAnexus Appoints David Fenstermacher as Vice President of Precision Medicine and Data Sciences
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte Unveils Next-Generation Percepta Genomic Sequencing Classifier for Improved Lung Cancer Diagnosis
MENLO PARK, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/IOCombos360?src=hash" target="_blank"gt;#IOCombos360lt;/agt;--Personalis Enters into a Research Agreement with FLX Bio to Provide Comprehensive Tumor Immunogenomic Profiling for Clinical Study.
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/bioinformatics?src=hash" target="_blank"gt;#bioinformaticslt;/agt;--DNAnexus Appoints Scott Gibson as Chief Financial Officer
SAN FRANCISCO--(BUSINESS WIRE)--Savonix to Present at Upcoming Industry & Scientific Conferences
SUNNYVALE, Calif.--(BUSINESS WIRE)--Druva, Inc., the leader in cloud data protection and management, today announced the National Cancer Institute (NCI), the federal government's primary agency addressing cancer research and treatment, is using Druva to replace its legacy hardware solutions for backup, restore and archiving of data. As the only FedRAMP certified data management solution, Druva’s unique technology ensures compliance with stringent government regulations and ease of management wi
WILMINGTON, Del.--(BUSINESS WIRE)--A new integrated analysis of Phase III data for FASENRA® (benralizumab) shows that patients with severe eosinophilic asthma who were continuously treated with the medicine for up to two years reduced their use of oral corticosteroids (OCS) and experienced a sustained improvement in exacerbation rates, lung function, asthma control and health-related quality of life. The analysis, presented today at the American Thoracic Society (ATS) 2019 International Confere
ARLINGTON, Va.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/EHR?src=hash" target="_blank"gt;#EHRlt;/agt;--Expanded award eligibility and updated criteria elevate industry leaders who make meaningful changes to enhance patient safety and healthcare delivery
CAMPBELL, Calif.--(BUSINESS WIRE)--Saama challenges analytics industry to guarantee data platforms to accelerate drug development; Saama Guarantee leads this call-to-action.
TAMPA, Fla.--(BUSINESS WIRE)--Phase 2 Clinical Trial Enrollment Progresses While World Health Organization Provides Generic Name of AG013 Compound
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announces that data from key studies within its inflammation and autoimmunity portfolio will be presented at the 24th World Congress of Dermatology (WCD). This meeting will be held in Milan, Italy from June 10-15, 2019. Presentations will feature 24-week data from a Phase 2 study of ruxolitinib cream in adult patients with vitiligo, which will be highlighted during the late-breaking research session, and 12-week data from a Pha
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--lt;a href="https://twitter.com/search?q=%24KALV&src=ctag" target="_blank"gt;$KALVlt;/agt;--KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, announced that data has been accepted for presentation at both the C1 Inhibitor Deficiency and Angioedema Workshop in Budapest, Hungary and European Academy of Allergy and Clinical Immunology (EAACI) Congress in Lisbon, Portugal. “We are excited to present
ANN ARBOR, Mich.--(BUSINESS WIRE)--lt;a href="https://twitter.com/search?q=%24KBLB&src=ctag" target="_blank"gt;$KBLBlt;/agt; lt;a href="https://twitter.com/hashtag/KBLB?src=hash" target="_blank"gt;#KBLBlt;/agt;--Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that its subsidiary Prodigy Textiles has taken possession of its factory in Vietnam. The Company is now retrofitting the nearly 50,000 square foot facility to produce its game changing recombinant spider silk materials. Remodeling efforts are expected to be minimal and completed quickly. This facility was selected based on its optimal
REDWOOD SHORES, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/AUA19?src=hash" target="_blank"gt;#AUA19lt;/agt;--New clinical data presented at AUA 2019 position PROCEPT BioRobotics' Aquablation therapy as new standard of care for patients suffering from BPH.
PETACH TIKVA, Israel--(BUSINESS WIRE)--Can-Fite’s Phase II Liver Cancer Data Selected for Presentation at a Leading Liver Cancer Scientific Forum (ILCA)
WAYNE, Pa.--(BUSINESS WIRE)--Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the schedule of key presentations to be featured during a lunch symposium at the 2019 New Cardiovascular Horizons (NCVH) Conference, May 29th through 31st at The Roosevelt New Orleans in New Orleans, Louisiana. Recently FDA-approved for above-the-knee interventions, the Tack Endovascular System is a first-of-its-kind dissection repair device i
WALTHAM, Mass.--(BUSINESS WIRE)--Clinique Pasteur is first European site to adopt latest CorPath GRX vascular robotic technology; Corindus to showcase technology at EuroPCR 2019
STAMFORD, Conn.--(BUSINESS WIRE)--SpringWorks Therapeutics Announces Initiation of Phase 3 Trial (DeFi) of Nirogacestat in Adult Patients with Desmoid Tumors
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Magellan Rx Management released its second Employer Market Insights Report, which highlights key areas of pharmacy trend and spend.
MEMPHIS, Tenn.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/Cancer?src=hash" target="_blank"gt;#Cancerlt;/agt;--Inteliquet has entered into a Cooperative Research and Development Agreement with NCI.
MENLO PARK, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/immuno19?src=hash" target="_blank"gt;#immuno19lt;/agt;--Personalis, Inc. to Present at Advances in Immuno-Oncology Congress UK 2019: Advancing Precision Oncology Biomarker Discovery with ImmunoID NeXT.
NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new study evaluates the ability of Masimo SpHb® (noninvasive hemoglobin) to help clinicians estimate when to conduct invasive measurement.
GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)--QIAGEN N.V. (NYSE:QGEN; Frankfurt Prime Standard:QIA) today announced the U.S. launch of its QIAstat-Dx syndromic testing system after receiving 510(k) clearance by the U.S. Food and Drug Administration, along with the multiplex QIAstat-Dx® Respiratory Panel for simultaneous qualitative detection and identification of multiple respiratory viral and bacterial pathogens. QIAstat-Dx (formerly Stat-Dx DiagCORE®) represents the next-generation in m
DALLAS--(BUSINESS WIRE)--lt;a href="https://twitter.com/search?q=%24RMD&src=ctag" target="_blank"gt;$RMDlt;/agt; lt;a href="https://twitter.com/hashtag/CPAP?src=hash" target="_blank"gt;#CPAPlt;/agt;--A million-patient study reveals gaps among various sub-populations in long-term adherence to CPAP for treating sleep apnea.
CHICAGO--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/DDW19?src=hash" target="_blank"gt;#DDW19lt;/agt;--New study shows SonarMD’s care coordination solution helps lower cost of managing Crohn’s disease.
BOSTON--(BUSINESS WIRE)--Gelesis announced the presentation of data from a clinical study of GS500 for potential treatment of chronic constipation at Digestive Disease Week.